Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ENDRA Life Sciences Inc NDRA

Healthcare Medical Devices
ENDRA Life Sciences Inc. is developing an enhanced ultrasound technology platform - Thermo Acoustic Enhanced Ultrasound (TAEUS), a technology which characterizes tissue similar to a magnetic resonance imaging (MRI). The Company's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into... see more

Recent & Breaking News (NDAQ:NDRA)

ENDRA Life Sciences Granted Two U.S. Patents For Correcting Fat-Induced Aberrations & Imaging Biological Tissue Structures

Accesswire July 31, 2018

ENDRA Life Sciences to Host Second Quarter 2018 Results Conference Call on Monday, August 13, 2018 at 4:30 p.m. ET

Accesswire July 25, 2018

ENDRA Life Sciences Granted U.S. Patent for Magnetic Resonance Imaging (MRI) Safety Based on TAEUS Technology

Accesswire July 12, 2018

ENDRA Life Sciences Completes Private Placement of $1.1 Million of Convertible Secured Notes and Warrants

Accesswire July 2, 2018

ENDRA Life Sciences Granted Third U.S. Patent for Non-Invasive Fat Assessment to Support TAEU(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease

Accesswire June 5, 2018

ENDRA Life Sciences Reports First Quarter 2018 Financial Results

Accesswire May 15, 2018

ENDRA Life Sciences to Host First Quarter 2018 Results Conference Call on Tuesday, May 15, 2018 at 4:30 p.m. ET

Accesswire April 26, 2018

ENDRA Life Sciences to Showcase Photoacoustic Imaging Technology at American Association for Cancer Research (AACR) Annual Meeting on April 14-18 in Chicago

Accesswire April 9, 2018

ENDRA Life Sciences to Present at The MicroCap Conference on Tuesday, April 10, 2018

Accesswire April 2, 2018

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2017 Financial Results

Accesswire March 20, 2018

ENDRA Life Sciences to Host Fourth Quarter and Full Year 2017 Results Conference Call on Tuesday, March 20, 2018 at 4:30 p.m. ET

Accesswire March 7, 2018

ENDRA Life Sciences to Present at the Inaugural LD Micro Virtual Conference on Tuesday, March 6, 2018 at 5:00 p.m. ET

Accesswire February 27, 2018

ENDRA Life Sciences Granted Two U.S. Patents for Non-Invasive Fat Assessment to Support TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease

Accesswire February 15, 2018

ENDRA Life Sciences Renews and Extends Term of Collaboration Agreement with GE Healthcare to Develop ENDRA's TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease

Accesswire February 5, 2018

ENDRA Life Sciences to Present at the 10th Annual LD Micro Main Event on December 6, 2017

Accesswire November 22, 2017

ENDRA Life Sciences Reports Third Quarter 2017 Financial Results

Accesswire November 15, 2017

ENDRA Life Sciences Contracts The Centre for Imaging Technology Commercialization (CIMTEC) to Initiate Human Studies with ENDRA's Clinical TAEUS(TM) Device Targeting Non-Alcoholic Fatty Liver Disease

Accesswire November 8, 2017

ENDRA Life Sciences Partners with StarFish Medical and CriTech Research to Commence Development of TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease

Accesswire November 2, 2017

ENDRA Life Sciences to Host Third Quarter 2017 Results Conference Call on Wednesday, November 15, 2017 at 4:30 p.m. ET

Accesswire October 23, 2017

ENDRA Life Sciences Completes Delivery and Installation of its Next Generation Nexus 128+ to Leading Research University in South Korea

Accesswire September 28, 2017